Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II Trial

OBJECTIVE: Anti-synthetase syndrome (anti-SS) is frequently associated with myositis and interstitial lung disease (ILD). We evaluated prospectively, in a multicenter, open-label, phase II study, the efficacy of rituximab on muscle and lung outcomes. METHODS: Patients were enrolled if they were refr...

Descripción completa

Detalles Bibliográficos
Autores principales: Allenbach, Yves, Guiguet, Marguerite, Rigolet, Aude, Marie, Isabelle, Hachulla, Eric, Drouot, Laurent, Jouen, Fabienne, Jacquot, Serge, Mariampillai, Kuberaka, Musset, Lucile, Grenier, Philippe, Devilliers, Herve, Hij, Adrian, Boyer, Olivier, Herson, Serge, Benveniste, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634756/
https://www.ncbi.nlm.nih.gov/pubmed/26539981
http://dx.doi.org/10.1371/journal.pone.0133702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634756/
https://www.ncbi.nlm.nih.gov/pubmed/26539981
http://dx.doi.org/10.1371/journal.pone.0133702

Ejemplares similares